메뉴 건너뛰기




Volumn 27, Issue 5, 2013, Pages 479-484

Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin

Author keywords

balanitis; dapagliflozin; genital infection; glucosuria sodium glucose cotransporter 2; SGLT2; vulvovaginitis

Indexed keywords

ALANINE AMINOTRANSFERASE; DAPAGLIFLOZIN; SODIUM GLUCOSE COTRANSPORTER 2;

EID: 84883799810     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.04.012     Document Type: Article
Times cited : (172)

References (20)
  • 1
    • 77953857048 scopus 로고    scopus 로고
    • Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: A randomised, double-blind, placebo-controlled trial
    • C.J. Bailey, J.L. Gross, A. Pieters, A. Bastien, and J.F. List Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: A randomised, double-blind, placebo-controlled trial Lancet 375 9733 2010, June 2223 2233
    • (2010) Lancet , vol.375 , Issue.9733 , pp. 2223-2233
    • Bailey, C.J.1    Gross, J.L.2    Pieters, A.3    Bastien, A.4    List, J.F.5
  • 2
    • 0031888707 scopus 로고    scopus 로고
    • Treatment of vulvovaginal candidiasis in patients with diabetes
    • N.J. Bohannon Treatment of vulvovaginal candidiasis in patients with diabetes Diabetes Care 21 3 1998, March 451 456
    • (1998) Diabetes Care , vol.21 , Issue.3 , pp. 451-456
    • Bohannon, N.J.1
  • 3
    • 18744378563 scopus 로고    scopus 로고
    • Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes
    • E.M. de Leon, S.J. Jacober, J.D. Sobel, and B. Foxman Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes BMC Infectious Diseases 2 2002 1
    • (2002) BMC Infectious Diseases , vol.2 , pp. 1
    • De Leon, E.M.1    Jacober, S.J.2    Sobel, J.D.3    Foxman, B.4
  • 4
    • 0141955625 scopus 로고    scopus 로고
    • Lower genital tract infections in diabetic women
    • G.G. Donders Lower genital tract infections in diabetic women Current infectious disease report 4 6 2002, December 536 539
    • (2002) Current Infectious Disease Report , vol.4 , Issue.6 , pp. 536-539
    • Donders, G.G.1
  • 5
    • 77956921439 scopus 로고    scopus 로고
    • Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
    • E. Ferrannini, S.J. Ramos, A. Salsali, W. Tang, and J.F. List Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial Diabetes Care 33 10 2010, October 2217 2224
    • (2010) Diabetes Care , vol.33 , Issue.10 , pp. 2217-2224
    • Ferrannini, E.1    Ramos, S.J.2    Salsali, A.3    Tang, W.4    List, J.F.5
  • 6
    • 84859030635 scopus 로고    scopus 로고
    • SGLT2 inhibitors: A new emerging therapeutic class in the treatment of type 2 diabetes mellitus
    • R.K. Ghosh, S.M. Ghosh, S. Chawla, and S.A. Jasdanwala SGLT2 inhibitors: A new emerging therapeutic class in the treatment of type 2 diabetes mellitus Journal of Clinical Pharmacology 52 4 2012, April 457 463
    • (2012) Journal of Clinical Pharmacology , vol.52 , Issue.4 , pp. 457-463
    • Ghosh, R.K.1    Ghosh, S.M.2    Chawla, S.3    Jasdanwala, S.A.4
  • 7
    • 0033758731 scopus 로고    scopus 로고
    • Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status
    • R. Goswami, V. Dadhwal, S. Tejaswi, and K. Datta Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status Journal of Infection 41 2 2000, September 162 166
    • (2000) Journal of Infection , vol.41 , Issue.2 , pp. 162-166
    • Goswami, R.1    Dadhwal, V.2    Tejaswi, S.3    Datta, K.4
  • 8
    • 48249146624 scopus 로고    scopus 로고
    • Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats
    • S. Han, D.L. Hagan, J.R. Taylor, and L. Xin Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats Diabetes 57 6 2008, June 1723 1729
    • (2008) Diabetes , vol.57 , Issue.6 , pp. 1723-1729
    • Han, S.1    Hagan, D.L.2    Taylor, J.R.3    Xin, L.4
  • 10
    • 65349196064 scopus 로고    scopus 로고
    • Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
    • J.F. List, V. Woo, E. Morales, W. Tang, and F.T. Fiedorek Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes Diabetes Care 32 4 2009, April 650 657
    • (2009) Diabetes Care , vol.32 , Issue.4 , pp. 650-657
    • List, J.F.1    Woo, V.2    Morales, E.3    Tang, W.4    Fiedorek, F.T.5
  • 11
    • 41649087328 scopus 로고    scopus 로고
    • Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
    • W. Meng, B.A. Ellsworth, A.A. Nirschl, and P.J. McCann Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes Journal of Medicinal Chemistry 51 5 2008, March 1145 1149
    • (2008) Journal of Medicinal Chemistry , vol.51 , Issue.5 , pp. 1145-1149
    • Meng, W.1    Ellsworth, B.A.2    Nirschl, A.A.3    McCann, P.J.4
  • 13
    • 33644688031 scopus 로고    scopus 로고
    • Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes
    • H. Rahmoune, P.W. Thompson, J.M. Ward, C.D. Smith, G. Hong, and J. Brown Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes Diabetes 54 12 2005, December 3427 3434
    • (2005) Diabetes , vol.54 , Issue.12 , pp. 3427-3434
    • Rahmoune, H.1    Thompson, P.W.2    Ward, J.M.3    Smith, C.D.4    Hong, G.5    Brown, J.6
  • 15
    • 84862875221 scopus 로고    scopus 로고
    • Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy
    • J. Rosenstock, M. Vico, L. Wei, A. Salsali, and J.F. List Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy Diabetes Care 35 7 2012, July 1473 1478
    • (2012) Diabetes Care , vol.35 , Issue.7 , pp. 1473-1478
    • Rosenstock, J.1    Vico, M.2    Wei, L.3    Salsali, A.4    List, J.F.5
  • 17
    • 80052524011 scopus 로고    scopus 로고
    • Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: A randomised, 24-week, double-blind, placebo-controlled trial
    • K. Strojek, K.H. Yoon, V. Hruba, M. Elze, A.M. Langkilde, and S. Parikh Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: A randomised, 24-week, double-blind, placebo-controlled trial Diabetes, Obesity & Metabolism 13 10 2011, October 928 938
    • (2011) Diabetes, Obesity & Metabolism , vol.13 , Issue.10 , pp. 928-938
    • Strojek, K.1    Yoon, K.H.2    Hruba, V.3    Elze, M.4    Langkilde, A.M.5    Parikh, S.6
  • 18
    • 69549095914 scopus 로고    scopus 로고
    • A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: Applicability of a novel insulin-independent treatment
    • J.P. Wilding, P. Norwood, C. T'joen, A. Bastien, J.F. List, and F.T. Fiedorek A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: Applicability of a novel insulin-independent treatment Diabetes Care 32 9 2009, September 1656 1662
    • (2009) Diabetes Care , vol.32 , Issue.9 , pp. 1656-1662
    • Wilding, J.P.1    Norwood, P.2    T'Joen, C.3    Bastien, A.4    List, J.F.5    Fiedorek, F.T.6
  • 19
    • 84858323889 scopus 로고    scopus 로고
    • Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: A randomized trial
    • J.P. Wilding, V. Woo, N.G. Soler, A. Pahor, J. Sugg, and K. Rohwedder Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: A randomized trial Annals of Internal Medicine 156 6 2012, March 405 415
    • (2012) Annals of Internal Medicine , vol.156 , Issue.6 , pp. 405-415
    • Wilding, J.P.1    Woo, V.2    Soler, N.G.3    Pahor, A.4    Sugg, J.5    Rohwedder, K.6
  • 20
    • 77953181310 scopus 로고    scopus 로고
    • Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: Effects on glycaemic control and body weight
    • L. Zhang, Y. Feng, J. List, S. Kasichayanula, and M. Pfister Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: Effects on glycaemic control and body weight Diabetes, Obesity & Metabolism 12 6 2010 510 516
    • (2010) Diabetes, Obesity & Metabolism , vol.12 , Issue.6 , pp. 510-516
    • Zhang, L.1    Feng, Y.2    List, J.3    Kasichayanula, S.4    Pfister, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.